The CNAT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNAT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CNAT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CNAT Detailed Price Forecast - CNN Money||View CNAT Detailed Summary - Google Finance|
|View CNAT Detailed Summary - Yahoo! Finance||View CNAT Stock Research & Analysis - Zacks.com|
|View CNAT Trends & Analysis - Trade-Ideas||View CNAT Major Holders - Barrons|
|View CNAT Call Transcripts - NASDAQ||View CNAT Breaking News & Analysis - Seeking Alpha|
|View CNAT Annual Report - CompanySpotlight.com||View CNAT OTC Short Report - OTCShortReport.com|
|View CNAT Fundamentals - TradeKing||View CNAT SEC Filings - Bar Chart|
|View Historical Prices for CNAT - The WSJ||View Performance/Total Return for CNAT - Morningstar|
|View the Analyst Estimates for CNAT - MarketWatch||View the Earnings History for CNAT - CNBC|
|View the CNAT Earnings - StockMarketWatch||View CNAT Buy or Sell Recommendations - MacroAxis|
|View the CNAT Bullish Patterns - American Bulls||View CNAT Short Pain Metrics - ShortPainBot.com|
|View CNAT Stock Mentions - StockTwits||View CNAT Stock Mentions - PennyStockTweets|
|View CNAT Stock Mentions - Twitter||View CNAT Investment Forum News - Investor Hub|
|View CNAT Stock Mentions - Yahoo! Message Board||View CNAT Stock Mentions - Seeking Alpha|
|View Insider Transactions for CNAT - SECform4.com||View Insider Transactions for CNAT - Insider Cow|
|View CNAT Major Holdings Summary - CNBC||View Insider Disclosure for CNAT - OTC Markets|
|View Insider Transactions for CNAT - Yahoo! Finance||View Institutional Holdings for CNAT - NASDAQ|
|View CNAT Stock Insight & Charts - FinViz.com||View CNAT Investment Charts - StockCharts.com|
|View CNAT Stock Overview & Charts - BarChart||View CNAT User Generated Charts - Trading View|
Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension
Posted on Thursday September 20, 2018
Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, will host an invitation-only symposium on portal hypertension for institutional investors and research analysts on Thursday, September 27, 2018, from 4:30 p.m. to 6:00 p.m. ET in New York. Guadalupe Garcia-Tsao, M.D., Professor of Medicine in the Section of Digestive Diseases at Yale School of Medicine, Director of the Clinical and Translational Core at Yale Liver Center, and Chief of the Section of Digestive Diseases at the Veterans Administration-Connecticut Health Care System, will address the clinical importance of portal hypertension.
Today's Research Reports on Trending Tickers: Conatus Pharmaceuticals and INSYS Therapeutics
Posted on Wednesday September 19, 2018
NEW YORK, NY / ACCESSWIRE / September 19, 2018 / U.S. markets closed up Tuesday on the strength of upbeat corporate earnings and strong economic data. On Tuesday, China announced tariffs of between 5 to ...
Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences
Posted on Wednesday September 19, 2018
Conatus Pharmaceuticals Inc. (CNAT) has accepted invitations to participate in two upcoming investor conferences. At the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease (September 26-27 in New York), senior management will conduct a series of scheduled meetings with investment professionals. At the Roth Capital Partners Battle of the NASH Thrones Investor Conference (October 17 in New York), senior management will conduct a series of scheduled meetings with investment professionals and participate in a panel discussion on fibrotic, inflammatory and metabolic agents.
Who Owns Most Of Conatus Pharmaceuticals Inc (NASDAQ:CNAT)?
Posted on Tuesday September 18, 2018
Every investor in Conatus Pharmaceuticals Inc (NASDAQ:CNAT) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to seeRead More...